CM, v. T., LB, K., S, P., R, S., AA, A., O, C., . . . O, W. (2024). LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
Citação norma ChicagoCM, van Tilburg, et al. LOGGIC/FIREFLY-2: A Phase 3, Randomized Trial of Tovorafenib Vs. Chemotherapy in Pediatric and Young Adult Patients With Newly Diagnosed Low-grade Glioma Harboring an Activating RAF Alteration. 2024.
Citação norma MLACM, van Tilburg, et al. LOGGIC/FIREFLY-2: A Phase 3, Randomized Trial of Tovorafenib Vs. Chemotherapy in Pediatric and Young Adult Patients With Newly Diagnosed Low-grade Glioma Harboring an Activating RAF Alteration. 2024.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.